""Bisphosphonate-related osteonecrosis of the jaw (BRONJ)" was the initially described entity, but "medication-related osteonecrosis of the jaw" is now the preferred term as other medications besides bisphosphonates have been implicated as aetiological agents 5,6."
"RANKL inhibitor monoclonal antibody"
"anti-TNF agents"
"poorly defined lucent, mixed or sclerotic lesion"